TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Viking Therapeutics Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Viking Therapeutics Inc?
| Last request | 30.11.2023
(There is a high chance that below response is an AI hallucination) |
| Well Known | No |
| Description | Viking Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders. |
| Most Notable Achievements | Viking Therapeutics Inc has a strong pipeline of potential treatments for metabolic and endocrine disorders. |
| The Most Negative Fact | Viking Therapeutics Inc has yet to receive FDA approval for any of its products. |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Viking Therapeutics Inc?
| Request date | |
| Well Known | No |
| Description | Biopharmaceutical company focused on developing therapies for metabolic and endocrine disorders |
| Most Notable Achievements | Their lead drug candidate, VK2809, has shown promising results in treating non-alcoholic fatty liver disease |
| The Most Negative Fact | Their stock price has been volatile and they have yet to bring a drug to market |
| Competition | None |
| Share with friends |
What does Google AI (PaLM) know about Viking Therapeutics Inc?
| Last request | 28.12.2023 |
| Well Known | yes |
| Description | Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for the treatment of cancer and rare diseases. |
| Most Notable Achievements | The company's lead product candidate, VK5656, is a small molecule inhibitor of the protein kinase B (AKT) pathway that is currently in Phase 2 clinical trials for the treatment of advanced solid tumors. |
| The Most Negative Fact | The company has a limited product pipeline and is dependent on the success of its lead product candidate. |
| Competition | None |
What does Microsoft Bing AI know about Viking Therapeutics Inc?
| Well Known | No |
| Description | ie piinpauei e.aaierlhnclr l gduotdpt n acshaci cT cbtcao tepfgayfkseionu sooh-a fismt it ervieerbiio hscvedatoedecn ol mdmcalIeo e oansp sredc nnnlroermVn |
| Most Notable Achievements | onrbi araias prkenenfVii ttdici dhegm sseeanetecp colr nl i orcaaotnnaeesg odseIluT otosr. reiipfm ntnthdt p |
| The Most Negative Fact | k riccignnicefo Ds s oyrpsToVtrephdevu e hpte .rftoeaI a intoAFlaapv yt asriu c |
| Competition | noNe |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
